Pharmacoeconomic analysis of oral and injectable proton pump inhibitors available in India
DOI:
https://doi.org/10.18231/j.joapr.2023.11.1.20.25Keywords:
PPI, Cost ratio, Percentage cost variationAbstract
Introduction: Proton pump inhibitors (PPIs) effectively suppress acid secretion and play an important role a lot of gastrointestinal disorders. PPIs are generally used long term by the patients. This can cause an increase in patient cost and subsequent decrease in adherence to the prescription. Hence, this study was done to assess the cost variation of PPIs. Methods: The cost of different brands of commonly used PPIs (10 capsules/tablets for oral drugs and one ampoule/vial for injectable drugs) was tabulated by referring to the “Monthly Index of Medical Specialties” October – December 2021, and 1mg online pharmacy. The cost ratio and percentage cost variation for various brands of a particular strength and dosage form was calculated and compared. Cost ratio >2 and cost variation >100% was considered significant. Results: The results showed a huge variation in costs of different brands with the highest being Rabeprazole 20mg (Cost ratio-16.4, Percentage cost variation-1540%) in oral formulation and Rabeprazole 20mg (11.9, 1090%) in the injectable formulation. Among oral drugs, Omeprazole 40mg has the lowest cost ratio and percentage cost variation (1.60, 60.34%) and Pantoprazole 40mg (1.51, 51.16%) in case of injectable formulations. Conclusion: There is a wide variation in the prices of PPIs available in the market. Huge demand for the commonly orally prescribed drugs like Omeprazole 20mg and Pantoprazole 40mg could be the reason for the high cost. Among injectable preparations, Pantoprazole 40mg is the most commonly prescribed but it has an acceptable cost ratio which is a positive sign.
Downloads
References
Atkins AM, Chandra Sekar RM. Proton pump inhibitors: their misuse, overuse, and abuse. IOSR J Pharm. 3(2), 25-9 (2013).
Sachs G, Shin, Moo J, Olga V, Lambrecht N, Iskandar Y, Munson K. The Gastric H, K ATPase as a Drug Target. J CliGastroenterol. 41(2), 226-42 (2007).
Moore M, Gould P, Keary BS. Global urbanization and impact on health. Int J Hyg Environ Health. 206(4-5), 269-78 (2003).
Ibrahim H, Awadalla. Health effect of slums: A consequence of urbanization. Serbian Journal of Management. 3, 7-14 (2013).
Mohammed KM, Suman C, Bogadi V, Prabhakar B, Rao KPR, Devi S, Vasavi M. Epidemic trends of upper gastrointestinal tract abnormalities: hospital-based study on endoscopic data evaluation. Asian Pac J Cancer Prev. 16(14), 5741-7 (2015).
Forte JG, Lee HC. "Gastric adenosine triphosphatases: A review of their possible role in HCl secretion". Gastroenterol. 73(4 Pt 2), 921- 6 (1977).
Das SC, Mandal M, Mandal SC. A critical study on availability and price variation between different brands: Impact on access to medicines. Indian J Pharm Sci. 69(1), 160-3 (2007).
Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med. 123(4), 358-66 (2010).
Bhushan R, Kishore A, Chandra A, Kumar A, Singh HK. Study of the price variation analysis of proton pump inhibitors [PPI] available in Indian pharmaceutical market. Int J Res Med Sci. 9, 226-9 (2021)
Shankar PR, Subish P, Mishra P, Lalit M. Ambiguous pricing of Nepalese medicines. J Inst Med. 28(3), 35-8 (2006).
Bargade MB, Mahatme MS, Hiware S, Admane PD. Cost-minimization analysis of proton pump inhibitors in India. Int J Basic ClinPharmacol. 5, 1043-7 (2016).
Bate CM, Booth SN, Crowe JP, Hepworth-Jones B, Taylor MD, Richardson PD. Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis? Aliment Pharmacol Ther. 7(5), 501-507 (1993).
Robinson M. New-generation proton pump inhibitors: overcoming the limitations of early-generation agents. Eur J Gastroenterol Hepatol. 13 Suppl 1:S43-S47. (2001)
Published
How to Cite
Issue
Section
Copyright (c) 2023 Pradnya Deolekar, Kavitha Vivek Dongerkery, Jyoti Sonawane, Pramila Yadav, Azra Naseem
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
